Dividend Daily RSS Feed RSS
Dividend Stocks

The Dividend Daily

Dividend stocks - News, notes, updates, and analysis, delivered fresh daily

Abbott Labs to Buy Belgian Chemicals Maker’s Pharma Unit for $6.6 Billion (ABT)

By Dividend.com Staff
September 28th, 2009

abbott-labs-to-buy-belgian-chemicals-makers-pharma-unit-for-6-6-billion-abt

Healthcare products maker Abbott Laboratories (ABT) said Monday that it is buying Belgium-based chemicals maker Solvay S.A.'s pharmaceutical unit for $6.6 billion.

Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.

Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!

Comments on this Article COMMENTS ON THIS ARTICLE

One Response to “Abbott Labs to Buy Belgian Chemicals Maker’s Pharma Unit for $6.6 Billion (ABT)”

  1. U.S. medical industry complex spending its market subsidies - SmartPlanet Says:
    September 28th, 2009 at 2:45 pm

    [...] Labs is buying the phama unit of Solvay Chemicals in Belgium for $6.6 billion cash. It’s their third big buy this month. They previously bought Evalve Inc. of Menlo Park, [...]

Leave a Reply

Your Comments:

Please type the Security Words below:

About This Article ABOUT THIS ARTICLE

You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Disclaimer: Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.